NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible violations of federal securities laws.
On February 4, 2025, before the market opened, Merck issued a press release announcing their fourth-quarter and full-year 2024 results. As part of the announcement, Merck disclosed setbacks to Gardasil's sales, highlighting a 3% decrease in sales in 2024 and, more directly, a decrease of 18% in the fourth quarter, with the blame largely placed upon lower demand in China. Despite recently obtaining approval of Gardasil for males in China as of January 2025, Merck announced that it would pause shipments of the drug to China "through at least midyear." As a result of these setbacks, the company withdrew its prior forecast for Gardasil to reach $11 billion in sales by 2030.
Following this news, Merck's stock price fell by $11.18 per share to open at $88.64 per share. To obtain additional information, go to:
https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=127130&wire=1
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP